<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02175251</url>
  </required_header>
  <id_info>
    <org_study_id>P120909</org_study_id>
    <secondary_id>IDRCB 2013-A00872-43</secondary_id>
    <nct_id>NCT02175251</nct_id>
  </id_info>
  <brief_title>Low and High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Resistant Auditory Hallucination in Schizophrenia</brief_title>
  <acronym>rTMS</acronym>
  <official_title>Low and High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Resistant Auditory Hallucination in Schizophrenia: a Double Blind Sham-controlled Randomised Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Auditory Hallucinations (AH) are experienced by 50 to 70% of subjects with schizophrenia.
      Almost a quarter of patients are medication resistant to such symptoms. The application of
      rTMS at low frequency in the left temporoparietal cortex reduces AH. A pilot study reported
      successful treatment of AH with high frequency rTMS. rTMS (20Hz) should be a shorter and an
      easier treatment for out-patients with schizophrenia compared to low stimulation treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      90 schizophrenia patients Diagnostic and Statistical Manual of Mental Disorders, 4th Edition,
      Text Revision (DSM IV-TR) criteria with persistent Auditory Hallucinations (AH) resistant to
      antipsychotic treatments will be recruited. A double blind sham-controlled randomized
      parallel study comparing three groups treated 10 session in 5 days with high frequency (20
      Hz), low frequency (1Hz) and sham-controlled condition rTMS. They will be followed 3 month
      and evaluated using Auditive Hallucination Rating Scale (AHRS), Scale for the Assessment of
      Positive Symptoms Scores (SAPS), Scale for the Assessment of Negative Symptoms Scores (SANS)
      and Positive And Negative Symptom Scale (PANSS) global score and Global Assessment of
      Functioning (GAF) score.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Actual">September 29, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the efficiency of high frequency (20Hz) repetitive Transcranial Magnetic Stimulation (rTMS) to the left temporoparietal cortex compared to sham controlled condition rTMS in term on Auditory Hallucinations reduction.</measure>
    <time_frame>5 day</time_frame>
    <description>Auditory Hallucinations improvement at 5-day was evaluate with AHRS (Auditory Hallucination Rating Scale) score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To compare the efficiency of low frequency (1Hz) to sham-controlled condition repetitive Transcranial Magnetic Stimulation (rTMS) in term of Auditory Hallucination reduction.</measure>
    <time_frame>5 days</time_frame>
    <description>Auditory Hallucinations improvement evaluated with Auditory Hallucination Rating Scale (AHRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To compare the efficiency of high frequency to low frequency (1Hz) in term of Auditory Hallucination reduction.</measure>
    <time_frame>5 days</time_frame>
    <description>Auditory Hallucinations improvement evaluated with Auditory Hallucination Rating Scale (AHRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To compare the maintenance of therapeutic effect for one month of high frequency to low frequency (1Hz) in term of Auditory Hallucination reduction.</measure>
    <time_frame>1 month</time_frame>
    <description>Auditory Hallucinations improvement evaluated with Auditory Hallucination Rating Scale (AHRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To evaluate the maintenance of therapeutic effect of high frequency compared to sham controlled condition for 15 days 1 month, 2 months and 3 months</measure>
    <time_frame>15 days 1 month, 2 months and 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To compare the side effects of each of the active treatment</measure>
    <time_frame>at Inclusion and 5 day</time_frame>
    <description>Tolerance assessed with the UDVALG of KLINISKE UNDERSOGELSER scale (UKU )</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>low frequency (1Hz)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>low frequency</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Comparator</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham Comparator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high frequency (20Hz)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>high frequency</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>high frequency (20Hz)</intervention_name>
    <description>10 session in 5 days with high frequency (20 Hz)</description>
    <arm_group_label>high frequency (20Hz)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>low frequency (1Hz)</intervention_name>
    <description>10 session in 5 days with low frequency (1Hz)</description>
    <arm_group_label>low frequency (1Hz)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham Comparator</intervention_name>
    <description>10 session in 5 days with sham-controlled</description>
    <arm_group_label>Sham Comparator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with schizophrenia DSM IV-TR criteria and persistent AH resistant to
             antipsychotic treatments.

        Exclusion Criteria:

          -  Left handed patients lateralizes

          -  rTMS contraindications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Caroline DUBERTRET, PU-PH</last_name>
    <role>Study Director</role>
    <affiliation>Department of Psychiatry, Louis MOURIER Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Psychiatry, Louis Mourier Hospital</name>
      <address>
        <city>Colombes</city>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2014</study_first_submitted>
  <study_first_submitted_qc>June 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2014</study_first_posted>
  <last_update_submitted>January 18, 2018</last_update_submitted>
  <last_update_submitted_qc>January 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>rTMS</keyword>
  <keyword>Schizophrenia</keyword>
  <keyword>high frequency rTMS</keyword>
  <keyword>low frequency rTMS</keyword>
  <keyword>AHRS</keyword>
  <keyword>SAPS SANS PANSS</keyword>
  <keyword>GAF</keyword>
  <keyword>UKU</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Hallucinations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

